Final-Program-ATS-2023-AP.vp

MONDAY • MAY 22

135

10:36 Distinct Epithelial-Innate Immune Cell Transcriptional Circuits Underlie Airway Hyperresponsiveness in Asthma/ R.C. Murphy, Seattle, WA 10:48 Fractional Exhaled Nitric Oxide Is a Stable Longitudinal

10:36 Use of a Multi-Center Weighted Lottery to Promote Equity in the Allocation of Scarce COVID Medications/ D.B. White, Pittsburgh, PA 10:48 Severe Neighborhood Deprivation and Symptom Burden Among Older Adults Following COVID-19 Infection/ J. Falvey, Baltimore, MD

Biomarker in Severe Asthma and Correlates With Markers of Systemic Inflammation/ E.A. Townsend, Madison, WI

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

B15

ASTHMA: HOT OFF THE PRESS FROM THE BENCH TO THE CLINIC

B16

THE CURRENT STATE OF CRITICAL CARE: ROLE OF SYSTEMS AND HEALTH DISPARITIES

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center West Salon G-I (Street Level)

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 204 A-C (Level 2)

Chairing: P. Lamothe, MD, PhD, Atlanta, GA M.L. Manni, PhD, Pittsburgh, PA C.R. Morris, PhD, Burlington, VT Oral Presentations: 9:00 Placebo Rates Confound Asthma Exacerbation Rate Reductions: A Meta-regression Analysis of Pivotal Trials of Three Anti-IL5 Biologics/ D.B. Khatry, Rockville, MD 9:12 Androgen Receptor (AR) Signaling Decreases Glutamine Metabolism in Th17 Cells to Decrease House Dust Mite-Induced Airway Inflammation/ N.U. Chowdhury, Nashville, TN 9:24 Cannabinoid Receptor 1 Inverse Agonist, INV-202, Induces Weight Loss and Reduces Airway Hyperreactivity in a Mouse Model of Obese Asthma/ C.R. Morris, Burlington, VT 9:36 Airway Epithelial Circular RNA Expression Is Altered in Asthma/ C. Huang, Wuhan, China 9:48 FeNO, Biomarkers of High Th2 Immunity, and Response to Inhaled Corticosteroids in African American Children With Asthma/ Y.-Y. Han, Pittsburgh, PA 10:00 Increased Numbers of Group 3 Innate Lymphoid Cells and C-kit-positive ILC2s Expressing IL-17A in Sputum From Severe Asthmatics With Neutrophilic or Mixed Granulocytic Bronchitis/ X. Ju, Hamilton, Canada 10:12 Pathologic CD8+ Effector Memory T Cells Re-expressing CD45RA in Severe Asthma/ R.P. Ramonell, Pittsburgh, PA 10:24 Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Prior Omalizumab Use: A Post Hoc Analysis of the Phase 3 Navigator Study/ A. Menzies-Gow, London, United Kingdom

Chairing: M.F. Griffith, MD, MPH, Aurora, CO R. Kohn, MD, MSCE, Philadelphia, PA K.R. Gillmeyer, MD, Boston, MA Oral Presentations: 9:00 The Earlier the Better: Timing of Transfer Is Associated With Improved Outcomes in Patients With Acute Respiratory Failure/ A. Ludwig, Chicago, IL 9:12 Implementing an Interdisciplinary Triage Huddle to Reduce ED to Medical ICU Wait Times/ S.M. Hyder, Chicago, IL 9:24 Admission to a TeleICU Hospital Is Associated With Similar Rates of Inter-Hospital Transfer but Improved 30-Day Mortality: A Patient-Level Instrumental Variable Analysis/ B. Deshpande, Ann Arbor, MI 9:36 One Versus Two Weeks of Physician Continuity in the Intensive Care Unit and Subsequent Outcomes: A Target Trial Emulation/ A.J. Admon, Ann Arbor, MI 9:48 Keeping Tabs on Sepsis: A Modified CDC Adult Sepsis Event (CDC-ASE) Definition/ K.J. Karlic, Ann Arbor, MI 10:00 Illness Presentation Characteristics Associated With Antimicrobial Timing and In-hospital Mortality Among Patients With Hospital-onset Sepsis/ J.C. Ginestra, Philadelphia, PA 10:12 An Intersectional Analysis of Sociodemographic Disparities in Hospital Mortality After Mechanical Ventilation for Pneumonia and Sepsis/ G.L. Day, Aurora, CO 10:24 A Retrospective Analysis of Differences in Sedation Practice by Race During Mechanical Ventilation/ D. Ramadurai, Philadelphia, PA

ATS 2023 • Washington, DC